Daehan New Pharm Co. Ltd Long-term Investment Intensity
Daehan New Pharm Co. Ltd long-term investment intensity. Daehan New Pharm Co. Ltd (054670) has a Long-term Investment Intensity of 26.2% as of September 2018. Long-term investments of ₩30.87 Billion represent 26.2% of total assets of ₩117.93 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read 054670 liabilities breakdown for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Daehan New Pharm Co. Ltd (2014–2017)
Long-term investment intensity of Daehan New Pharm Co. Ltd from 2014 to 2017. This chart shows how Daehan New Pharm Co. Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2014 to 2017. As of September 2018, the intensity stands at 26.2%, reflecting long-term investments of ₩30.87 Billion against total assets of ₩117.93 Billion KRW.
Daehan New Pharm Co. Ltd Long-term Investment Intensity by Year (2014–2017)
Daehan New Pharm Co. Ltd long-term investment intensity by year from 2014 to 2017. The table below presents the year-by-year Long-term Investment Intensity for Daehan New Pharm Co. Ltd from 2014 to 2017, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Daehan New Pharm Co. Ltd balance sheet assets.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2017 | 27.2% | ₩33.09 Billion | ₩121.82 Billion | ▲ +1.2 pp |
| 2016 | 25.9% | ₩33.88 Billion | ₩130.72 Billion | ▼ -8.4 pp |
| 2015 | 34.3% | ₩45.53 Billion | ₩132.63 Billion | ▼ -0.8 pp |
| 2014 | 35.1% | ₩45.83 Billion | ₩130.47 Billion | — |